Ruling Is Victory for Drug Companies in Promoting Medicine for Other Uses

NY Times  By KATIE THOMAS  Published: December 3, 2012   In a case that could have broad ramifications for the pharmaceutical industry, a federal appeals court on Monday threw out the conviction of a sales representative who sold a drug for uses not approved by the Food and Drug Administration. The judges said that the ban on so-called off-label marketing violated the representative’s freedom of speech.  Read more